Patents by Inventor Sean Marks

Sean Marks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12263172
    Abstract: Provided herein are formulations and methods of using a TLR-7 agonist for the treatment of hepatitis B virus infection.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: April 1, 2025
    Assignee: CHIA TAI TIANQING PHARMECEUTICAL GROUP CO., LTD.
    Inventors: Peter Jozef M Van Remoortere, Sean Mark Dalziel, Ilham Smyej, Joris Jozef Vandenbossche, An Martine M De Creus, Mina Pastagia, Florence Marie Herschke
  • Publication number: 20240423920
    Abstract: Provided herein are high strength/high drug load tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde (“Compound 1”), dispersible tablets comprising Compound 1, processes of manufacturing such tablets, and methods for treating patients with the tablets. Compound 1 is useful for treating hematological disorders such as sickle cell disease, pulmonary disease such as idiopathic pulmonary fibrosis, and hypoxia and hypoxemia conditions.
    Type: Application
    Filed: September 10, 2024
    Publication date: December 26, 2024
    Applicant: Global Blood Therapeutics, Inc.
    Inventors: Sean Mark Dalziel, Naveen Bejugam, Nazila Habibizad, Ali Komeyli, DeMei Leung
  • Publication number: 20240340626
    Abstract: A system and method are provided for the management of electronic data representing emergency alerts. The system includes a server that receives data records representing an emergency event and computes a corresponding severity metric. If the severity metric exceeds a threshold, the server transmits a control signal from a server to a computing device. The control signal can cause the computing device to control an alarm system, vehicle navigation system, automated email system, user interface, or automated messaging system.
    Type: Application
    Filed: June 19, 2024
    Publication date: October 10, 2024
    Inventors: Louise Noelle TIERNEY, James Andrew NEUFELD, Sean Mark SOLBAK, Adam Joseph ST ARNAUD
  • Patent number: 12029709
    Abstract: The present disclosure relates to an inhalable formulation, suitable for use in a dry powder inhaler, for the delivery of epinephrine, or a pharmaceutically acceptable salt or derivative thereof. The inhalable formulation further comprises a solid carrier and results in a stable formulation with useful physical properties for delivery to the lungs of a subject in need of epinephrine.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: July 9, 2024
    Assignee: De Motu Cordis Pty Ltd
    Inventors: John Fraser, Sean Mark Dalziel, Teresa Iley, Jonathan Brazier, Patrick Joseph Lynch, John Fredatovich, Benjamin Barnaby Trout
  • Patent number: 12022371
    Abstract: A system and method are provided for the management of electronic data representing emergency alerts. The system includes a server that receives social media data records representing an emergency event and computes a corresponding severity metric. If the severity metric exceeds a threshold, the server transmits a control signal from a server to a computing device. The control signal can cause the computing device to control an alarm system, vehicle navigation system, automated email system, user interface, or automated messaging system.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: June 25, 2024
    Assignee: SOCIAL ASSET MANAGEMENT INC.
    Inventors: Louise Noelle Tierney, James Andrew Neufeld, Sean Mark Solbak, Adam Joseph St Arnaud
  • Publication number: 20240050382
    Abstract: The present disclosure relates to an inhalable formulation, suitable for use in a dry powder inhaler, for the delivery of epinephrine, or a pharmaceutically acceptable salt or derivative thereof. The inhalable formulation further comprises a solid carrier and results in a stable formulation with useful physical properties for delivery to the lungs of a subject in need of epinephrine.
    Type: Application
    Filed: August 11, 2022
    Publication date: February 15, 2024
    Inventors: John Fraser, Sean Mark Dalziel, Teresa Iley, Jonathan Brazier, Patrick Joseph Lynch, John Fredatovich, Benjamin Barnaby Trout
  • Publication number: 20220249488
    Abstract: Provided herein are formulations and methods of using a TLR-7 agonist for the treatment of hepatitis B virus infection.
    Type: Application
    Filed: March 13, 2020
    Publication date: August 11, 2022
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Peter Jozef M VAN REMOORTERE, Sean Mark DALZIEL, Ilham SMYEJ, Joris Jozef VANDENBOSSCHE, An Martine M DE CREUS, Mina PASTAGIA, Florence Marie HERSCHKE
  • Publication number: 20220201455
    Abstract: A system and method are provided for the management of electronic data representing emergency alerts. The system includes a server that receives social media data records representing an emergency event and computes a corresponding severity metric. If the severity metric exceeds a threshold, the server transmits a control signal from a server to a computing device. The control signal can cause the computing device to control an alarm system, vehicle navigation system, automated email system, user interface, or automated messaging system.
    Type: Application
    Filed: December 18, 2020
    Publication date: June 23, 2022
    Inventors: Louise Noelle TIERNEY, James Andrew NEUFELD, Sean Mark SOLBAK, Adam Joseph ST ARNAUD
  • Publication number: 20210283061
    Abstract: Provided herein are high strength/high drug load tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde (“Compound 1”), dispersible tablets comprising Compound 1, processes of manufacturing such tablets, and methods for treating patients with the tablets. Compound 1 is useful for treating hematological disorders such as sickle cell disease, pulmonary disease such as idiopathic pulmonary fibrosis, and hypoxia and hypoxemia conditions.
    Type: Application
    Filed: January 20, 2021
    Publication date: September 16, 2021
    Inventors: Sean Mark Dalziel, Naveen Bejugam, Nazila Habibizad, Ali Komeyli, DeMei Leung
  • Publication number: 20210011895
    Abstract: According to examples, an apparatus may include a processor that may divide content of a document to be indexed into sections. The apparatus may divide and arrange each section into a hierarchy based on linguistic, spatial, or other analysis. The apparatus may identify a context of each section that may provide an indication of the subject matter of the section. The apparatus may add the context to downstream sections in the hierarchy. The apparatus may generate an index entry for each section based on the content of the section and any added context from upstream sections. Thus, the index entry for a given section may be based on the context of the given section and context of upstream sections in the hierarchy. In this way, the index entries may account for not only the content of the given section, but also context from upstream sections.
    Type: Application
    Filed: July 11, 2019
    Publication date: January 14, 2021
    Applicant: LONGSAND LIMITED
    Inventors: Sean Mark BLANCHFLOWER, Brian Gibson COWE
  • Patent number: 10493035
    Abstract: Provided herein are high strength/high drug load tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde (“Compound 1”), dispersible tablets comprising Compound 1, processes of manufacturing such tablets, and methods for treating patients with the tablets. Compound 1 is useful for treating hematological disorders such as sickle cell disease, pulmonary disease such as idiopathic pulmonary fibrosis, and hypoxia and hypoxemia conditions.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: December 3, 2019
    Assignee: Global Blood Therapeutics, Inc.
    Inventors: Sean Mark Dalziel, Naveen Bejugam, Nazila Habibizad, Ali Komeyli, DeMei Leung
  • Patent number: 10348766
    Abstract: A method, system and program product for group policy backup management in a network having a plurality of domains including components and modules for steps of retrieving a list of group policy objects for a domain, generating a configuration initialization file including a domains section identifying a plurality of domains that are to be backed up and a setup section specifying a plurality of values that control the backup of each policy object in each domain, determining a digital signature for each policy object on a list of policies for the domain, comparing the digital signature for each policy object with a corresponding previous digital signature for each policy, determining if a current digital signature for each policy object matches the corresponding previous digital signature for a policy, and backing up a policy object having a current digital signature that does not match the corresponding previous digital signature.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: July 9, 2019
    Assignee: OPEN INVENTION NETWORK LLC
    Inventors: Colin Lee Feeser, Ryan Sean Marks
  • Publication number: 20180125789
    Abstract: Provided herein are high strength/high drug load tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde (“Compound 1”), dispersible tablets comprising Compound 1, processes of manufacturing such tablets, and methods for treating patients with the tablets. Compound 1 is useful for treating hematological disorders such as sickle cell disease, pulmonary disease such as idiopathic pulmonary fibrosis, and hypoxia and hypoxemia conditions.
    Type: Application
    Filed: October 12, 2017
    Publication date: May 10, 2018
    Inventors: Sean Mark Dalziel, Naveen Bejugam, Nazila Habibizad, Ali Komeyli, DeMei Leung
  • Patent number: 9688666
    Abstract: The present disclosure relates to novel crystalline salt forms of lamivudine, methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of viruses such as Human Immunodeficiency Virus (HIV) infection.
    Type: Grant
    Filed: February 6, 2014
    Date of Patent: June 27, 2017
    Assignee: TOBIRA THERAPEUTICS, INC.
    Inventors: Sean Mark Dalziel, Mark Michael Menning
  • Patent number: 9691184
    Abstract: According to an example, a computer may receive characteristics information of an object in a video stream captured by a first computing device, generate a signature based on the characteristics information, identify an augmented reality information associated with the signature, transmit the augmented reality information to the first computing device, receive, from a second computing device, a set of characteristics information of the object in an image captured by the second computing device, determine that the set of characteristics information from the second computing device has a second signature that matches the signature generated based on the characteristics information received form the first computing device, and transmit the identified augmented reality information to the second computing device.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: June 27, 2017
    Assignee: Aurasma Limited
    Inventors: Sean Mark Blanchflower, Simon Hayhurst
  • Patent number: 9535797
    Abstract: A method, system and program product for group policy backup management in a network having a plurality of domains including components and modules for steps of retrieving a list of group policy objects for a domain, generating a configuration initialization file including a domains section identifying a plurality of domains that are to be backed up and a setup section specifying a plurality of values that control the backup of each policy object in each domain, determining a digital signature for each policy object on a list of policies for the domain, comparing the digital signature for each policy object with a corresponding previous digital signature for each policy, determining if a current digital signature for each policy object matches the corresponding previous digital signature for a policy, and backing up a policy object having a current digital signature that does not match the corresponding previous digital signature.
    Type: Grant
    Filed: January 20, 2014
    Date of Patent: January 3, 2017
    Assignee: Open Invention Network, LLC
    Inventors: Colin Lee Feeser, Ryan Sean Marks
  • Patent number: 9530251
    Abstract: The systems and methods may allow mobile computing devices to identify real world trigger items and to cause augmented reality scenarios associated with a real world trigger item to be presented on a display of the mobile computing device. A lookup scheme may identify indexed feature points of known candidate trigger items stored in a database. A number of evaluations occur between the indexed feature points to the feature points found in the real world trigger item. A determination that the feature points of a candidate trigger item matches the feature points of the real world trigger item is made when a confidence threshold is met or exceeded based on at least the look up scheme, weighted factor evaluation, variable threshold evaluation and potentially a geometric consistency evaluation to declare a positive match.
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: December 27, 2016
    Assignee: Aurasma Limited
    Inventors: James Loxam, Sean Mark Blanchflower
  • Patent number: 9458188
    Abstract: A new method for the synthesis of L-Glutamyl-?-D-Glutamic acid and its use in the synthesis of (2R)-((4S)-carboxy-4-(4,N-(((6S)-2-(hydroxymethyl)-4-oxo-3,4,7,8-tetrahydro-3H-cyclopenta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino)benzamido)butanamido)pentanedioic acid, 1 are provided. Also provided is an efficient method for the isolation and purification of the trisodium salt of the abovementioned acid, 2, in a form suitable for long term storage and use in a parenteral dosing form.
    Type: Grant
    Filed: December 19, 2011
    Date of Patent: October 4, 2016
    Assignee: BTG INTERNATIONAL LIMITED
    Inventors: James Alan Kerschen, Alexander James Bridges, Milind D. Choubal, Sean Mark Dalziel, Thomas Elliott Jacks, Andrew S. Thompson, James Robert Zeller
  • Patent number: 9430876
    Abstract: The systems and methods may allow mobile computing devices to identify real world trigger items and to cause augmented reality scenarios associated with a real world trigger item to be presented on a display of the mobile computing device. A lookup scheme may identify indexed feature points of known candidate trigger items stored in a database. A number of evaluations occur between the indexed feature points to the feature points found in the real world trigger item. A determination that the feature points of a candidate trigger item matches the feature points of the real world trigger item is made when a confidence threshold is met or exceeded based on at least the look up scheme, weighted factor evaluation, variable threshold evaluation and potentially a geometric consistency evaluation to declare a positive match.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: August 30, 2016
    Assignee: Aurasma Limited
    Inventors: James Loxam, Sean Mark Blanchflower
  • Patent number: 9338589
    Abstract: The systems and methods allow users of mobile computing devices to generate augmented reality scenarios. Augmented reality content is paired with a real world trigger item to generate the augmented reality scenario. The augmented reality content is overlaid onto frames on a video when a trigger item is detected. Each mobile computing device may have an augmented reality application resident on the mobile computing device to allow a user to generate the augmented reality scenarios.
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: May 10, 2016
    Assignee: Aurasma Limited
    Inventors: James Loxam, Sean Mark Blanchflower